120 related articles for article (PubMed ID: 38512353)
1. Diseases of Hereditary Renal Cell Cancers.
Iliopoulos O
Urol Clin North Am; 2023 May; 50(2):205-215. PubMed ID: 36948667
[TBL] [Abstract][Full Text] [Related]
2. Genetically driven predisposition leads to an unusually genomic unstable renal cell carcinoma.
Scimeca M; Rovella V; Caporali S; Shi Y; Bischof J; Woodsmith J; Tisone G; Sica G; Amelio I; Melino G; Mauriello A; Bove P
Discov Oncol; 2024 Mar; 15(1):80. PubMed ID: 38512353
[TBL] [Abstract][Full Text] [Related]
3. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.
Wu J; Wang H; Ricketts CJ; Yang Y; Merino MJ; Zhang H; Shi G; Gan H; Linehan WM; Zhu Y; Ye D
Cancer; 2019 Apr; 125(7):1060-1069. PubMed ID: 30548481
[TBL] [Abstract][Full Text] [Related]
4. Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes.
Gatalica Z; Lilleberg SL; Monzon FA; Koul MS; Bridge JA; Knezetic J; Legendre B; Sharma P; McCue PA
Hum Pathol; 2011 Dec; 42(12):1979-88. PubMed ID: 21733559
[TBL] [Abstract][Full Text] [Related]
5. BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
Pennington KP; Walsh T; Lee M; Pennil C; Novetsky AP; Agnew KJ; Thornton A; Garcia R; Mutch D; King MC; Goodfellow P; Swisher EM
Cancer; 2013 Jan; 119(2):332-8. PubMed ID: 22811390
[TBL] [Abstract][Full Text] [Related]
6. A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers.
Natrajan R; Mackay A; Lambros MB; Weigelt B; Wilkerson PM; Manie E; Grigoriadis A; A'Hern R; van der Groep P; Kozarewa I; Popova T; Mariani O; Turaljic S; Furney SJ; Marais R; Rodruigues DN; Flora AC; Wai P; Pawar V; McDade S; Carroll J; Stoppa-Lyonnet D; Green AR; Ellis IO; Swanton C; van Diest P; Delattre O; Lord CJ; Foulkes WD; Vincent-Salomon A; Ashworth A; Stern MH; Reis-Filho JS
J Pathol; 2012 May; 227(1):29-41. PubMed ID: 22362584
[TBL] [Abstract][Full Text] [Related]
7. Hereditary Renal Cancer Syndromes.
Yanus GA; Kuligina ES; Imyanitov EN
Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390862
[TBL] [Abstract][Full Text] [Related]
8. A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient.
Han Y; Rovella V; Smirnov A; Buonomo OC; Mauriello A; Perretta T; Shi Y; Woodmsith J; Bischof J; ; Melino G; Candi E; Bernassola F
Cell Death Discov; 2023 Oct; 9(1):370. PubMed ID: 37813891
[TBL] [Abstract][Full Text] [Related]
9. A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency.
Yang X; Smirnov A; Buonomo OC; Mauriello A; Shi Y; Bischof J; Woodsmith J; ; Melino G; Candi E; Bernassola F
Cell Death Discov; 2023 Oct; 9(1):365. PubMed ID: 37783677
[TBL] [Abstract][Full Text] [Related]
10. Progress and prospects in research and clinical practice of hormone receptor-positive, HER-2-negative breast cancer with BRCA1/2 mutations.
Yan S; Imam M
Discov Oncol; 2023 Jun; 14(1):110. PubMed ID: 37351713
[TBL] [Abstract][Full Text] [Related]
11. CINmetrics: an R package for analyzing copy number aberrations as a measure of chromosomal instability.
Oza VH; Fisher JL; Darji R; Lasseigne BN
PeerJ; 2023; 11():e15244. PubMed ID: 37123011
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Vitale I; Pietrocola F; Guilbaud E; Aaronson SA; Abrams JM; Adam D; Agostini M; Agostinis P; Alnemri ES; Altucci L; Amelio I; Andrews DW; Aqeilan RI; Arama E; Baehrecke EH; Balachandran S; Bano D; Barlev NA; Bartek J; Bazan NG; Becker C; Bernassola F; Bertrand MJM; Bianchi ME; Blagosklonny MV; Blander JM; Blandino G; Blomgren K; Borner C; Bortner CD; Bove P; Boya P; Brenner C; Broz P; Brunner T; Damgaard RB; Calin GA; Campanella M; Candi E; Carbone M; Carmona-Gutierrez D; Cecconi F; Chan FK; Chen GQ; Chen Q; Chen YH; Cheng EH; Chipuk JE; Cidlowski JA; Ciechanover A; Ciliberto G; Conrad M; Cubillos-Ruiz JR; Czabotar PE; D'Angiolella V; Daugaard M; Dawson TM; Dawson VL; De Maria R; De Strooper B; Debatin KM; Deberardinis RJ; Degterev A; Del Sal G; Deshmukh M; Di Virgilio F; Diederich M; Dixon SJ; Dynlacht BD; El-Deiry WS; Elrod JW; Engeland K; Fimia GM; Galassi C; Ganini C; Garcia-Saez AJ; Garg AD; Garrido C; Gavathiotis E; Gerlic M; Ghosh S; Green DR; Greene LA; Gronemeyer H; Häcker G; Hajnóczky G; Hardwick JM; Haupt Y; He S; Heery DM; Hengartner MO; Hetz C; Hildeman DA; Ichijo H; Inoue S; Jäättelä M; Janic A; Joseph B; Jost PJ; Kanneganti TD; Karin M; Kashkar H; Kaufmann T; Kelly GL; Kepp O; Kimchi A; Kitsis RN; Klionsky DJ; Kluck R; Krysko DV; Kulms D; Kumar S; Lavandero S; Lavrik IN; Lemasters JJ; Liccardi G; Linkermann A; Lipton SA; Lockshin RA; López-Otín C; Luedde T; MacFarlane M; Madeo F; Malorni W; Manic G; Mantovani R; Marchi S; Marine JC; Martin SJ; Martinou JC; Mastroberardino PG; Medema JP; Mehlen P; Meier P; Melino G; Melino S; Miao EA; Moll UM; Muñoz-Pinedo C; Murphy DJ; Niklison-Chirou MV; Novelli F; Núñez G; Oberst A; Ofengeim D; Opferman JT; Oren M; Pagano M; Panaretakis T; Pasparakis M; Penninger JM; Pentimalli F; Pereira DM; Pervaiz S; Peter ME; Pinton P; Porta G; Prehn JHM; Puthalakath H; Rabinovich GA; Rajalingam K; Ravichandran KS; Rehm M; Ricci JE; Rizzuto R; Robinson N; Rodrigues CMP; Rotblat B; Rothlin CV; Rubinsztein DC; Rudel T; Rufini A; Ryan KM; Sarosiek KA; Sawa A; Sayan E; Schroder K; Scorrano L; Sesti F; Shao F; Shi Y; Sica GS; Silke J; Simon HU; Sistigu A; Stephanou A; Stockwell BR; Strapazzon F; Strasser A; Sun L; Sun E; Sun Q; Szabadkai G; Tait SWG; Tang D; Tavernarakis N; Troy CM; Turk B; Urbano N; Vandenabeele P; Vanden Berghe T; Vander Heiden MG; Vanderluit JL; Verkhratsky A; Villunger A; von Karstedt S; Voss AK; Vousden KH; Vucic D; Vuri D; Wagner EF; Walczak H; Wallach D; Wang R; Wang Y; Weber A; Wood W; Yamazaki T; Yang HT; Zakeri Z; Zawacka-Pankau JE; Zhang L; Zhang H; Zhivotovsky B; Zhou W; Piacentini M; Kroemer G; Galluzzi L
Cell Death Differ; 2023 May; 30(5):1097-1154. PubMed ID: 37100955
[TBL] [Abstract][Full Text] [Related]
13. Assessing the pathogenicity of
De Paolis E; Paris I; Tilocca B; Roncada P; Foca L; Tiberi G; D'Angelo T; Pavese F; Muratore M; Carbognin L; Garganese G; Masetti R; Di Leone A; Fabi A; Scambia G; Urbani A; Generali D; Minucci A; Santonocito C
Front Oncol; 2022; 12():1053035. PubMed ID: 36741700
[TBL] [Abstract][Full Text] [Related]
14. SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.
Feng H; Wang T; Ye J; Yang Y; Huang X; Lai D; Lv Z; Huang Y; Zhang X
Discov Oncol; 2022 Dec; 13(1):134. PubMed ID: 36477668
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
